Search Results - "Schocken, DD"

The 4th Report of the Working Group on ECG diagnosis of Left Ventricular Hypertrophy by Bacharova, Ljuba, MD, DSc, Estes, Harvey E, MD, Schocken, Douglas D, MD, Ugander, Martin, MD, PhD, Soliman, Elsayed Z, MD, MSc, MS, Hill, Joseph A, MD, PhD, Bang, Lia E, MD, Schlegel, Todd T, MD

“…Abstract The 4th Report provides a brief review of publications focused on the electrocardiographic diagnosis of left ventricular hypertrophy published during…”
Get full text

Prevalence and mortality rate of congestive heart failure in the United States by Schocken, Douglas D., Arrieta, Martha I., Leaverton, Paul E., Ross, Eric A.

“…Objectives. The study was designed to determine the prevalence and mortality rate of congestive heart failure in noninstitutionalized men and women in the U.S…”
Get full text

Are Sleep Complaints an Independent Risk Factor for Myocardial Infarction? by Schwartz, Skai W., Cornoni-Huntley, Joan, Cole, Stephen R., Hays, Judith C., Blazer, Dan G., Schocken, Douglas D.

“…PURPOSE: To investigate whether subjective sleep complaints are an independent predictor of myocardial infarction (MI) in a community of older adults and to…”
Get full text

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators by DAGGUBATI, S, PARKS, J. R, OVERTON, R. M, CINTRON, G, SCHOCKEN, D. D, VESELY, D. L

“…The present investigation was designed to determine the best endogenous plasma marker of early congestive heart failure (CHF). Forty volunteers with mild CHF…”
Get full text

Role of Cytokines in the Mechanism of Action of Amlodipine: The PRAISE Heart Failure Trial by Mohler, Emile R, Sorensen, Leif C, Ghali, Jalal K, Schocken, Douglas D, Willis, Park W, Bowers, John A, Cropp, Anne B, Pressler, Milton L

“…Objectives. We sought to determine whether the beneficial effects of amlodipine in heart failure may be mediated by a reduction in tumor necrosis factor-alpha…”
Get full text

Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy by MARTIN GERDES, A, KELLERMAN, S. E, MOORE, J. A, MUFFLY, K. E, CLARK, L. C, REAVES, P. Y, MALEC, K. B, MCKEOWN, P. P, SCHOCKEN, D. D

“…Chronic ischemic heart disease may lead to ventricular dilation and congestive heart failure (ischemic cardiomyopathy [ICM]). The changes in cardiac myocyte…”
Get full text

Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans by VESELY, D. L, DOUGLASS, M. A, DIETZ, J. R, GOWER, W. R, MCCORMICK, M. T, RODRIGUEZ-PAZ, G, SCHOCKEN, D. D

“…Three peptides consisting of amino acids 1-30, 31-67, and 79-98 of the 126-amino acid atrial natriuretic factor prohormone (proANF), which have blood…”
Get full text

Blood pressure as a predictor of cardiovascular events in the elderly: the William Hale Research Program by MASLEY, S. C, PHILLIPS, S. E, SCHOCKEN, D. D

“…This study evaluates the association between blood pressure (BP) and the risk of developing cardiovascular disease (CVD) events in the elderly. The Morton…”
Get full text

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure by VESELY, D. L, DIETZ, J. R, PARKS, J. R, BAIG, M, MCCORMICK, M. T, CINTRON, G, SCHOCKEN, D. D

“…Vessel dilator, a 37-amino acid peptide hormone synthesized in the heart, enhances urine flow 4- to 12-fold and sodium excretion 3- to 6-fold in healthy…”
Get full text

Epidemiology and risk factors for heart failure in the elderly by Schocken, D D

“…Heart failure is a common problem in the elderly population, affecting 10% or more of persons more than 80 years of age. Heart failure is most likely to…”
Get more information

Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol by VESELY, David L, SAN MIGUEL, Gloria I, HASSAN, Imran, SCHOCKEN, Douglas D

“…The present investigation was designed to determine whether atrial natriuretic peptides consisting of amino acids 1-30 (i.e. long-acting natriuretic hormone),…”
Get full text

Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E 2 by Vesely, David L., Perez-Lamboy, Gloria I., Schocken, Douglas D.

“…Prostaglandin E 2 (PGE 2) increases in the circulation of persons with congestive heart failure (CHF), but the cause of this increase is unknown…”
Get full text

Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure by Nasser, Ali, Dietz, John R, Siddique, Maqsood, Patel, Hamang, Khan, Nadim, Antwi, Ernest K, San Miguel, Gloria I, McCormick, Michael T, Schocken, Douglas D, Vesely, David L

“…Kaliuretic peptide, a 20-amino acid peptide hormone synthesized in the heart, enhances urine flow twofold, whereas atrial natriuretic peptide (ANP) enhances…”
Get full text

Negative feedback of atrial natriuretic peptides by Vesely, D L, Douglass, M A, Dietz, J R, Giordano, A T, McCormick, M T, Rodriguez-Paz, G, Schocken, D D

“…The present investigation was designed to determine whether atrial natriuretic peptides consisting of amino acids 1-30 [i.e. pro-ANF-(1-30)], 31-67 [i.e…”
Get more information

Diabetic Cardiomyopathy and Carnitine Deficiency by Malone, John I, Schocken, Douglas D, Morrison, Anthony D, Gilbert-Barness, Enid

“…This study was designed to study the pathogenesis of cardiomyopathy in animals with longstanding (6 months) diabetes mellitus. Male Wistar rats were made…”
Get full text

Intact negative feedback of four cardiac hormones in congestive heart failure by Vesely, David L., San Miguel, Gloria I., Hassan, Imran, Schocken, Douglas D.

“…In 30 individuals with class III congestive heart failure (CHF), negative feedback of 4 cardiac peptide hormones, ie, long-acting natriuretic peptide (LANP),…”
Get full text

Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure by Vesely, David L., Dietz, John R., Parks, James R., Antwi, Ernest A., Overton, Rose M., McCormick, Michael T., Cintron, Guillermo, Schocken, Douglas D.

“…Background Long-acting natriuretic peptide (LANP; proANF 1-30) and vessel dilator (proANF 31-67) enhance sodium and water excretion in healthy human beings…”
Get full text

Atrial natriuretic hormone, vessel dilator, long acting natriuretic hormone, and kaliuretic hormone decrease circulating prolactin concentrations by Vesely, D L, San Miguel, G I, Hassan, I, Schocken, D D

“…The present investigation was designed to test whether four cardiac hormones--long acting natriuretic hormone, vessel dilator, kaliuretic hormone and atrial…”
Get more information

Comparison of habitual runners and anorexia nervosa patients by Powers, P.S. (University of South Florida, Tampa, FL.), Schocken, D.D, Boyd, F.R

“…Psychological and physiological similarities have been proposed between habitual runners and anorexia nervosa patients. Method: Twenty male runners, 20 female…”
Get full text

A comparison of two measures of quality-of life for congestive heart failure by Nordbrock, IE, Schwartz, SW, Schocken, DD

Get full text